KSA
PJP icon

Ken Stern & Associates’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ken Stern & Associates’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-67,334
Closed -$4.71M – 84
2015
Q4 		$4.71M Buy
67,334
+40,213
+148% +$2.85M 3.16% 14
2015
Q3 		$1.8M Sell
27,121
-2,687
-9% -$209K 1.4% 18
2015
Q2 		$2.33M Sell
29,808
-29,672
-50% -$2.31M 1.69% 18
2015
Q1 		$4.54M Sell
59,480
-1,897
-3% -$139K 3.41% 10
2014
Q4 		$4.08M Buy
+61,377
New +$4.09M 3.18% 13

Other funds holding PJP

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Ken Stern & Associates's PJP Position: Q1 2016 in Review

Ken Stern & Associates sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 67,334 shares — an estimated $4.71M sold.

Ken Stern & Associates first reported a position in PJP in Q4 2014 and held it in 5 quarters. The position peaked at $4.71M in Q4 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

  • Ken Stern & Associates reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
  • Ken Stern & Associates sold 67,334 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $4.71M.
  • Ken Stern & Associates first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 5 quarters.
  • Ken Stern & Associates's Invesco Pharmaceuticals ETF position peaked at $4.71M in Q4 2015.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Ken Stern & Associates's 13F filing for Q1 2016, filed 7 Jun 2016.